About Element Biosciences
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets.
Mission & Story
Mission
Our mission is to empower the scientific community with more freedom and flexibility to accelerate our collective impact on humanity.
Founding Story
Element Biosciences is founded and led by industry veterans who believe that high-quality sequencing doesn't have to come at a high price.
Clinical Focus
Medical conditions and clinical areas addressed by Element Biosciences.
Who It Serves
Milestones & Awards
Recent Milestones
Announced upsized Series E funding June 2026; Achieved ISO 13485 certification June 2026; Introduced VITARI high-throughput platform 2026; Launched AVITI24 multiomics platform 2026; Responded to 10x Genomics patent infringement complaint May 2026
Awards & Recognition
Testimonials from major institutions including Broad Institute, 10x Genomics, Google Health Genomics highlighting superior performance and data quality
Key Partnerships
Social & Media
Follow on
Latest Updates
.jpeg)
Why the NGI at SciLifeLab chose AVITI24™ and what they’ve discovered since
3d ago
.jpeg)
NGS for MRD Detection: Sensitivity Requirements and Platform Comparison
2w ago
.jpeg)
Webinar Digest: Optical Pooled CRISPR Screening Reveals Regulators of NF-κB Dynamics in Human Cells
3w ago
.jpeg)
Strand-seq: A single cell sequencing technology coming into its own
1mo ago
.jpeg)
Spatially resolved variant calling in cancer tissue
2mo ago
Company Details
- Founded
- 2017
- Headquarters
- San Diego, CA, USA
- Employees
- 375
- Stage
- growth
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 60 →
23andMe
23andMe uses AI to analyze genetic data and provide personalized health summaries, risk assessments, and wellness recommendations based on genomic insights.
2bPrecise
AI-powered precision medicine platform for personalized treatment recommendations and genomic analysis.
ACT Genomics
AI-powered genomic analysis platform for precision medicine and personalized treatment recommendations.
Adaptive Biotechnologies
Adaptive Biotechnologies uses AI and machine learning to decode the immune system and identify disease-specific immune signatures for diagnosis and personalized treatment.
Ambry Genetics
Ambry Genetics is a leading clinical genetic testing laboratory specializing in hereditary cancer, rare disease, cardiology, and neurology testing. The company provides advanced genetic testing solutions with paired DNA/RNA analysis and comprehensive patient support programs.
Ataraxis
Ataraxis develops AI-native precision medicine tools that predict patient outcomes and treatment response in oncology. Their flagship product, Ataraxis Breast, provides clinically validated prognostic and predictive tests for breast cancer using multi-modal AI analysis of pathology images and clinical data.
Avenda Health
Avenda Health develops Unfold AI, an FDA-cleared artificial intelligence platform that creates 3D cancer estimation maps for prostate cancer. The technology analyzes standard-of-care data (MRI, biopsy, pathology, PSA) to visualize cancer location and extent, helping physicians make more informed treatment decisions and improve patient outcomes.
Base Genomics
Base Genomics appears to be a company in the Precision Medicine & Genomics space, but the scraped website content is empty or inaccessible, preventing detailed analysis of their offerings and target market.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.